封面
市场调查报告书
商品编码
2008098

体外诊断试剂(IVD)原料市场:按产品、技术、最终用户和地区划分

IVD Raw Materials Market, By Product, By Technology, By End-User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2026年体外诊断(IVD)原物料市场规模预估为342.816亿美元,预计2033年将达507.906亿美元。预计2026年至2033年,该市场将以5.8%的复合年增长率成长。

分析范围 分析详情
基准年 2025 市场规模(2026 年) 342.816亿美元
效能数据 2020-2024 预测期 2026-2033
预测期(2026-2033 年)复合年增长率 5.80% 预计金额(2033 年) 507.906亿美元

体外诊断 (IVD) 检测可以检测疾病和病症,监测整体健康状况,并辅助疾病的治疗、管理和/或预防。 IVD 检测用于诊断多种疾病,包括心血管疾病、癌症、糖尿病、感染疾病、肾臟疾病、自体免疫疾病和 HIV/AIDS。 IVD 检测使用取自人体的血液或组织样本进行。简而言之,IVD 原料用于确定人体的健康状况。 IVD 试剂和试剂盒的关键原料包括抗体、抗原和酶,这些是决定试剂和试剂盒品质和有效性的关键因素。

市场动态

COVID-19 疫情、慢性病的高发生率、体外诊断技术的进步、照护现场普及、老年人口的增长以及伴随诊断的重要性日益增加,这些都是预计在预测期内推动全球 IVD 原材料市场增长的关键因素。

2021年8月,罗氏公司获得FDA核准,其VENTANA MMR RxDx Panel是一种用于识别符合抗PD-1免疫疗法条件的dMMR固体癌患者的诊断性PCR检测。此外,2020年5月,ERBA 食品药物管理局 Mannheim GmbH宣布推出ErbaLisa COVID-19 ELISA试剂盒,这是一种基于免疫检测的试剂盒,用于检测针对SARS-CoV-2的IgG和IgM抗体。 2020年3月,雅培公司推出了RealTime SARS-CoV-2检测,这是一种用于诊断COVID-19的PCR检测;Biomedomics公司推出了照护现场COVID-19检测,可在15分钟内检测血液中的抗体。

本报告的主要特点

  • 本报告对全球体外诊断原料市场进行了详细分析,包括预测期(2022-2030 年)的市场规模和复合年增长率,以 2021 年为基准年。
  • 此外,它还确定了每个细分市场的潜在商机,并描述了该市场中一系列有吸引力的投资提案。
  • 此外,它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
  • 本文檔根据以下参数介绍了全球体外诊断原材料市场主要企业的概况:公司概况、产品系列、主要亮点、财务表现和策略。
  • 本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
  • 《全球体外诊断原料市场》报告面向该产业的众多相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过分析全球体外诊断原材料市场中使用的各种策略矩阵来促进决策。

目录

第一章:分析目标与假设

  • 分析目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章:市场动态、监管与趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 法规环境
  • 产品上市/核准
  • PEST分析
  • 波特五力分析
  • 併购趋势

第四章 全球体外诊断原料市场:依产品划分(2026-2033 年)

  • 抗体/抗原
  • 酵素
  • 蛋白质
  • 生物缓衝液
  • 其他的

第五章:全球体外诊断原料市场(依技术划分)(2026-2033 年)

  • 临床化学
    • 介绍
    • 市场规模、预测及年增速
  • 免疫化学
    • 介绍
    • 市场规模、预测及年增速
  • 分子诊断
    • 介绍
    • 市场规模、预测及年增速
  • 其他的
    • 介绍
    • 市场规模、预测及年增速

第六章 全球体外诊断原料市场:依最终使用者划分(2026-2033 年)

  • 製药、生技和医疗科技公司
  • 诊断检查室
  • 其他的

第七章 全球体外诊断原料市场:依地区划分(2026-2033年)

  • 北美洲
  • 我们
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东和非洲
  • 波湾合作理事会(GCC)国家
  • 以色列
  • 其他中东国家
  • 南非
  • 中非
  • 北非
  • 世界其他地区

第八章 竞争情势

  • Aalto Bio Reagents
  • Fapon Biotech
  • Fujirebio
  • Merck KgaA
  • Hoffmann-La Roche
  • Thermo Fisher Scientific

第九章

  • 分析方法
  • 关于 Coherent Market Insights
简介目录
Product Code: CMI5234

IVD Raw Materials Market is estimated to be valued at USD 34,281.6 Mn in 2026 and is expected to reach USD 50,790.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 34,281.6 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 5.80% 2033 Value Projection: USD 50,790.6 Mn

In vitro diagnostics can detect diseases/conditions, and can be used to monitor overall health to help cure, treat, and/or prevent diseases. In vitro diagnostics are utilized to diagnose a wide range of medical disorders, such as cardiovascular disease, cancer, diabetes, infectious disease, nephrology, autoimmune diseases, and HIV/AIDS. IVD are tests done on the blood sample or tissue sample that have been taken from the human body. In short, IVD raw materials used to determine the status of a person's health. The core raw materials of in vitro diagnostic (IVD) reagents/kits include antibodies, antigens, enzymes, etc., which are important determinants of the quality and effectiveness of the reagents/kits.

Market Dynamics

The outbreak of COVID-19, high prevalence of chronic diseases, advanced technologies in in vitro diagnostic products, rise in use of point-of-care diagnostics, rising geriatric population, and growing significance of companion diagnostics are some major factors expected to boost the growth of the global IVD raw materials market during the forecast period.

In August 2021, Roche received the U.S. Food and Drug Administration (FDA) approval for VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy. Moreover, in May 2020, ERBA Diagnostics Mannheim GmbH announced the launch of its immunoassay-based kit, ErbaLisa COVID-19 ELISA kits, for the detection of IgG and IgM antibodies to SARS-CoV-2. In March 2020, Abbott launched the RealTime SARS-CoV-2 assay, a PCR-based test, for the diagnosis of COVID-19, and BioMedomics launched a point-of-care COVID-19 test that can detect antibodies in blood within 15 minutes.

Key features of the study

  • This report provides in-depth analysis of the global IVD raw materials market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global IVD raw materials market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Aalto Bio Reagents, Fapon Biotech, Fujirebio, Merck KgaA, F. Hoffmann-La Roche, Thermo Fisher Scientific, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global IVD raw materials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global IVD raw materials market.

Market Segmentation

  • Global IVD Raw Materials Market, By Product
    • Antibodies & Antigens
    • Enzymes
    • Proteins
    • Biological Buffers
    • Others
  • Global IVD Raw Materials Market, By Technology
    • Clinical Chemistry
    • Immunochemistry
    • Molecular diagnostics
    • Others
  • Global IVD Raw Materials Market, By End-User
    • Pharma, Biotech & MedTech Companies
    • Diagnostic Laboratories
    • Others
  • Global IVD Raw Materials Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Global IVD Raw Materials Market: Key Players
    • Aalto Bio Reagents
    • Fapon Biotech
    • Fujirebio
    • Merck KgaA
    • Hoffmann-La Roche
    • Thermo Fisher Scientific

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Technology
    • Market Snapshot, By End User
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global IVD Raw Materials Market, By Product, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Antibodies & Antigens
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Enzymes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Proteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Biological Buffers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global IVD Raw Materials Market, Technology, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Clinical Chemistry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Immunochemistry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Molecular diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global IVD Raw Materials Market, By End User, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Pharma, Biotech & MedTech Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

7. Global IVD Raw Materials Market, By Geography, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • South Africa
  • Central Africa
  • North Africa
  • Rest of World

8. Competitive Landscape

  • Aalto Bio Reagents
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fapon Biotech
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fujirebio
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KgaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hoffmann-La Roche
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us